文献速递头颈外科

头颈癌根治性治疗后随访的患者偏好:一项横断面预试验

Patients' preferences concerning follow-up after curative head and neck cancer treatment: A cross-sectional pilot study.
PubMed 文献 · Head Neck · 2019-02-05

该横断面调查在三级门诊随访患者中开展,101例中89.1%偏好定期随访而非症状自我转诊,57%希望减少就诊次数,85.1%支持定期影像检查。复发或第二原发与偏好强化随访方案相关(P=0.02),女性及高恐惧复发评分者有偏好强化随访的趋势。三分之二参与者表示愿意参加随机对照试验。

要点

  • 89.1%的患者偏好定期随访而非症状自我转诊。
  • 57%的患者希望随访次数少于当前标准。
  • 85.1%的患者支持定期影像检查。

核心结论

  • 患者偏好仅部分符合现行随访指南,招募随机对照试验评估随访价值似乎可行。

研究设计与样本

  • 横断面调查,在三级门诊随访患者中开展,共101例。

主要发现

  • 101例中89.1%偏好定期随访而非自我转诊,57%偏好少于当前标准的随访次数,85.1%支持定期影像检查。
  • 复发或第二原发与偏好强化随访方案相关(P=0.02)。
  • 女性和高恐惧复发评分患者有偏好强化随访的趋势。
  • 三分之二参与者表示愿意参加随机对照试验。

关键数值与推荐

  • 复发或第二原发与偏好强化随访方案相关(P=0.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence of the oncological benefit of scheduled follow-up in head and neck squamous cell carcinoma is weak; symptom-oriented self-referral may be an alternative. Patients' preferences regarding follow-up remain poorly investigated. METHODS: We conducted a cross-sectional survey among patients undergoing follow-up at a tertiary outpatient clinic, focusing on their preferences, correlating factors, fear of recurrence, and willingness for participation in a randomized trial on follow-up. RESULTS: Of 101 patients, 89.1% preferred scheduled follow-up to self-referral, 57% favored fewer visits than the current standard, and 85.1% endorsed regular imaging. Recurrence or second primary was associated with preference of intensive follow-up schedules (P = 0.02). There were trends for women and patients with high fear of recurrence score to favor intensive follow-up. Two-third of the participants declared willingness to participate in a randomized controlled trial. CONCLUSIONS: Patients' preferences only partially correspond to current follow-up guidelines. Recruitment for randomized controlled studies evaluating the value of follow-up seems feasible.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Mueller SA, Riggauer J, Elicin O, et al. Patients' preferences concerning follow-up after curative head and neck cancer treatment: A cross-sectional pilot study. Head Neck. 2019. PMID: 30723984. doi:10.1002/hed.25686

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。